Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of THELPER cells following stem cell transplantation

Virology

Volumn 397, Issue 2, 2010, Pages 277-284

  Serangeli, Celine ^a   Bicanic, Oliver ^a   Scheible, Michael H ^a   Wernet, Dorothee ^c   Lang, Peter ^a   Rammensee, Hans Georg ^b   Stevanovic, Stefan ^b   Handgretinger, Rupert ^a   Feuchtinger, Tobias ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Institute for Cell Biology   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Adenovirus; CD4 T cells; Hexon protein; MHC II

Indexed keywords

EPITOPE; GAMMA INTERFERON; HEXON PROTEIN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR7 ANTIGEN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS INFECTION; ADOLESCENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; EX VIVO STUDY; GENE SEQUENCE; GRAFT RECIPIENT; GRAFT REJECTION; HELPER CELL; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; IMMUNE RESPONSE; IMMUNODETECTION; NUCLEOTIDE SEQUENCE; ORGAN DONOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION SITE; SCHOOL CHILD; STEM CELL TRANSPLANTATION;

ADENOVIRUSES, HUMAN; ADOLESCENT; CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHILD; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON-GAMMA; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES, HELPER-INDUCER;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

EID: 75749092551     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.10.049     Document Type: Article

References (29)

1. Chakrabarti S., Mautner V., Osman H., Collingham K.E., Fegan C.D., Klapper P.E., Moss P.A., and Milligan D.W. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100 (2002) 1619-1627
2. De Rosa S.C., Brenchley J.M., and Roederer M. Beyond six colors: a new era in flow cytometry. Nat. Med. 9 (2003) 112-117
3. Eyrich M., Lang P., Lal S., Bader P., Handgretinger R., Klingebiel T., Niethammer D., and Schlegel P.G. A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors. Br. J. Haematol. 114 (2001) 422-432
4. Feuchtinger T., Lang P., Hamprecht K., Schumm M., Greil J., Jahn G., Niethammer D., and Einsele H. Isolation and expansion of human adenovirus specific CD4+ and CD8+ T-cells according to IFN-gamma secretion for adjuvant immunotherapy. Exp. Hematol. 32 (2004) 282-289
5. Feuchtinger T., Lucke J., Hamprecht K., Richard C., Handgretinger R., Schumm M., Greil J., Bock T., Niethammer D., and Lang P. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br. J. Haematol. 128 (2005) 503-509
6. Feuchtinger T., Matthes-Martin S., Richard C., Lion T., Fuhrer M., Hamprecht K., Handgretinger R., Peters C., Schuster F.R., Beck R., Schumm M., Lotfi R., Jahn G., and Lang P. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br. J. Haematol. 134 (2006) 64-76
7. Feuchtinger T., Richard C., Joachim S., Scheible M., Schumm M., Hamprecht K., Martin D., Jahn G., Handgretinger R., and Lang P. Clinical grade generation of Hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation. J. Immunother. (1997.) 31 (2008) 199-206
8. Flomenberg P., Babbitt J., Drobyski W.R., Ash R.C., Carrigan D.R., Sedmak G.V., McAuliffe T., Camitta B., Horowitz M.M., and Bunin N. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J. Infect. Dis. 169 (1994) 775-781
9. Flomenberg P., Piaskowski V., Truitt R.L., and Casper J.T. Characterization of human proliferative T cell responses to adenovirus. J. Infect. Dis. 171 (1995) 1090-1096
10. Handgretinger R., Lang P., Schumm M., Pfeiffer M., Gottschling S., Demirdelen B., Bader P., Kuci S., Klingebiel T., and Niethammer D. Immunological aspects of haploidentical stem cell transplantation in children. Ann. N.Y. Acad. Sci. 938 (2001) 340-357
11. Heemskerk B., Lankester A.C., van Vreeswijk T., Beersma M.F., Claas E.C., Veltrop-Duits L.A., Kroes A.C., Vossen J.M., Schilham M.W., and van Tol M.J. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J. Infect. Dis. 191 (2005) 520-530
12. Heemskerk B., van Vreeswijk T., Veltrop-Duits L.A., Sombroek C.C., Franken K., Verhoosel R.M., Hiemstra P.S., van Leeuwen D., Ressing M.E., Toes R.E., van Tol M.J., and Schilham M.W. Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction. J. Immunol. 177 (2006) 8851-8859
13. Kojaoghlanian T., Flomenberg P., and Horwitz M.S. The impact of adenovirus infection on the immunocompromised host. Rev. Med. Virol. 13 (2003) 155-171
14. Lang P., Handgretinger R., Niethammer D., Schlegel P.G., Schumm M., Greil J., Bader P., Engel C., Scheel-Walter H., Eyrich M., and Klingebiel T. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood 101 (2003) 1630-1636
15. Leen A.M., Sili U., Vanin E.F., Jewell A.M., Xie W., Vignali D., Piedra P.A., Brenner M.K., and Rooney C.M. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood 104 (2004) 2432-2440
16. Leen A.M., Christin A., Khalil M., Weiss H., Gee A.P., Brenner M.K., Heslop H.E., Rooney C.M., and Bollard C.M. Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. J. Virol. 82 (2008) 546-554
17. Lion T., Baumgartinger R., Watzinger F., Matthes-Martin S., Suda M., Preuner S., Futterknecht B., Lawitschka A., Peters C., Potschger U., and Gadner H. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102 (2003) 1114-1120
18. Mohty M., Jacot W., Faucher C., Bay J.O., Zandotti C., Collet L., Choufi B., Bilger K., Tournilhac O., Vey N., Stoppa A.M., Coso D., Gastaut J.A., Viens P., Maraninchi D., Olive D., and Blaise D. Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen. Leukemia 17 (2003) 2168-2177
19. Molinier-Frenkel V., Gahery-Segard H., Mehtali M., Le Boulaire C., Ribault S., Boulanger P., Tursz T., Guillet J.G., and Farace F. Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J. Virol. 74 (2000) 7678-7682
20. Molinier-Frenkel V., Lengagne R., Gaden F., Hong S.S., Choppin J., Gahery-Segard H., Boulanger P., and Guillet J.G. Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J. Virol. 76 (2002) 127-135
21. Olive M., Eisenlohr L., Flomenberg N., Hsu S., and Flomenberg P. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum. Gene Ther. 13 (2002) 1167-1178
22. Onion D., Crompton L.J., Milligan D.W., Moss P.A., Lee S.P., and Mautner V. The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein. J. Gen. Virol. 88 (2007) 2417-2425
23. Rux J.J., Kuser P.R., and Burnett R.M. Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods. J. Virol. 77 (2003) 9553-9566
24. Shirali G.S., Ni J., Chinnock R.E., Johnston J.K., Rosenthal G.L., Bowles N.E., and Towbin J.A. Association of viral genome with graft loss in children after cardiac transplantation. N. Engl. J. Med. 344 (2001) 1498-1503
25. Tang J., Olive M., Champagne K., Flomenberg N., Eisenlohr L., Hsu S., and Flomenberg P. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Ther 11 (2004) 1408-1415
26. Tang J., Olive M., Pulmanausahakul R., Schnell M., Flomenberg N., Eisenlohr L., and Flomenberg P. Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins. Virology 350 (2006) 312-322
27. Veltrop-Duits L.A., Heemskerk B., Sombroek C.C., van Vreeswijk T., Gubbels S., Toes R.E., Melief C.J., Franken K.L., Havenga M., van Tol M.J., and Schilham M.W. Human CD4+ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus. Eur. J. Immunol. 36 (2006) 2410-2423
28. Walls T., Shankar A.G., and Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect. Dis. 3 (2003) 79-86
29. Yusuf U., Hale G.A., Carr J., Gu Z., Benaim E., Woodard P., Kasow K.A., Horwitz E.M., Leung W., Srivastava D.K., Handgretinger R., and Hayden R.T. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 81 (2006) 1398-1404